Pfizer: all 4,072 studies
Page 26 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- A Study Comparing Amounts of Tafamidis (PF-06291826) in the Blood Without Food in Healthy VolunteersCompletedNCT02746926Phase 1
- Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese AdultsCompletedNCT02725437Phase 1
- Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine ProphylaxisWithdrawnNCT02718677
- Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234TerminatedNCT02711462Phase 1
- A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin LymphomaTerminatedNCT02702141Phase 1
- A Study Comparing Amounts of Tafamidis In The Blood Without FoodCompletedNCT02697864Phase 1
- Bioavailability Study Of PF-06651600 In Healthy SubjectsCompletedNCT02684760Phase 1
- Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human HyaluronidaseTerminatedNCT02667223Phase 1
- Single Dose Study of PF-06815345 in Healthy SubjectsTerminatedNCT02654899Phase 1
- Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)WithdrawnNCT02653989Phase 2
- A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy ParticipantsCompletedNCT02629289Phase 1
- Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy SubjectsCompletedNCT02609139Phase 1
- Food Effect Study PF-04136309CompletedNCT02598206Phase 1
- A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult SubjectsCompletedNCT02572245Phase 1
- PPI And Food Effect Study For PF-06463922 In Healthy VolunteersCompletedNCT02569554Phase 1
- A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy SubjectsCompletedNCT02567695Phase 1
- Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy SubjectsCompletedNCT02567682Phase 1
- A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male VolunteersCompletedNCT02564562Phase 1
- A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult SubjectsCompletedNCT02539550Phase 1
- Single Dose Study of PF-05230907 in Healthy Japanese SubjectsCompletedNCT02537002Phase 1
- A Study Comparing Amounts of Tafamidis In The Blood With Or Without FoodCompletedNCT02534740Phase 1
- Dose Escalation Study of PF-06741086 In Healthy SubjectsCompletedNCT02531815Phase 1
- A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing SpondylitisCompletedNCT02528201Phase 4
- Safety And Efficacy Of BosutinibCompletedNCT02501330
- A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male SubjectsCompletedNCT02497924Phase 1
- A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy VolunteersCompletedNCT02487433Phase 1
- Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy SubjectsCompletedNCT02485769Phase 1
- An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy SubjectsWithdrawnNCT02475746Phase 1
- Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric PatientsNo longer availableNCT02473497
- A Study Of PF-03084014 In Japanese Patients With Advanced Solid TumorsWithdrawnNCT02462707Phase 1
- Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy VolunteersCompletedNCT02458209Phase 1
- A Phase 1 Study To Characterize The Safety, Tolerability, PK And PK Of Repeat Doses Of PF-06648671 In Healthy Adults And Healthy Elderly SubjectsCompletedNCT02440100Phase 1
- Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib PharmacokineticsCompletedNCT02430545Phase 1
- A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography ScanningCompletedNCT02410525Phase 1
- A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)CompletedNCT02407353Phase 1
- A Study Comparing The Amounts of Tafamidis In The Blood With Or Without FoodCompletedNCT02406560Phase 1
- The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension FormulationWithdrawnNCT02393807Phase 1
- A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult SubjectsCompletedNCT02391623Phase 1
- Safety Study of SEA-CD40 in Cancer PatientsTerminatedNCT02376699Phase 1
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's DiseaseCompletedNCT02373072Phase 1
- Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 YearsCompletedNCT02364596Phase 1
- Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAPCompletedNCT02364284
- Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain EndpointsCompletedNCT02349607Phase 1
- A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AMLCompletedNCT02326584Phase 1
- A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy SubjectsCompletedNCT02316756Phase 1
- Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative TherapyNo longer availableNCT02312037
- A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of PalbociclibCompletedNCT02311946Phase 1
- Safety and Pharmacokinetic Study of PF-06651600 in Healthy VolunteersCompletedNCT02309827Phase 1
- A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy MalesTerminatedNCT02306876Phase 1
- A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung CancerWithdrawnNCT02297425Phase 2
- A Single Oral Dose Study Of PF-06409577 In Healthy Adult SubjectsTerminatedNCT02286882Phase 1
- A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell DiseaseCompletedNCT02285088Phase 1
- Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway MutationsCompletedNCT02278133Phase 1/2
- Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast CancerCompletedNCT02270372Phase 1
- A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly VolunteersCompletedNCT02265718
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy SubjectsCompletedNCT02262767Phase 1
- Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain EndpointsCompletedNCT02260947Phase 1
- Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain EndpointsCompletedNCT02238717Phase 1
- A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, MalesCompletedNCT02237742Phase 1
- A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))CompletedNCT02237729Phase 1
- Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed ConditionsCompletedNCT02224651Phase 1
- Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)CompletedNCT02222441Phase 1
- A Bioequivalence Study Comparing Two Different Tafamidis FormulationsCompletedNCT02217813Phase 1
- Food Effect Study for PF-06372865CompletedNCT02217787Phase 1
- Safety Study of SGN-CD70A in Cancer PatientsCompletedNCT02216890Phase 1
- A Single Oral Dose Study Of PF-06427878 In Healthy Adult SubjectsCompletedNCT02208284Phase 1
- Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy VolunteersCompletedNCT02207699Phase 1
- A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed ConditionsCompletedNCT02201511Phase 1
- Absolute Bioavailability Of BosutinibCompletedNCT02192294Phase 1
- A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood SamplesCompletedNCT02189330Phase 1
- A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed ConditionsCompletedNCT02184429Phase 1
- Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life SettingCompletedNCT02184416
- A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649TerminatedNCT02170012Phase 1
- AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy SubjectsCompletedNCT02163161Phase 1
- Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult VolunteersCompletedNCT02160158Phase 1
- Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and HaematologyCompletedNCT02158169
- A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649CompletedNCT02151617Phase 1
- Investigation Of The Metabolism, And Excretion Of [14c]-PF-05212384 In Healthy Male VolunteersCompletedNCT02142920Phase 1
- Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed AppropriateNo longer availableNCT02142868
- Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and OncologyCompletedNCT02140736
- A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865CompletedNCT02138500Phase 1
- Effect Of Itraconazole On The Pharmacokinetics Of PalbociclibCompletedNCT02131298Phase 1
- A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male VolunteersCompletedNCT02124213Phase 1
- A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The BodyCompletedNCT02110342Phase 1
- Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLCWithdrawnNCT02109653Phase 2
- Drug Interaction Study Between Bosutinib And DabigatranCompletedNCT02102633Phase 1
- Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal WomenCompletedNCT02100553Phase 1
- Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne VulgarisWithdrawnNCT02100527Phase 2
- Dacomitinib (PF-00299804) Pharmacokinetics In Chinese Healthy VolunteersCompletedNCT02097433Phase 1
- Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And FoodCompletedNCT02097329Phase 1
- A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)CompletedNCT02092922Phase 2
- Study Of Palbociclib (PD-0332991) In Renal ImpairmentCompletedNCT02085538Phase 1
- A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese VolunteersCompletedNCT02084875Phase 1
- PH-797804 LPS Study in Healthy VolunteersCompletedNCT02084485Phase 1
- Relative Bioavailability For Palbociclib FormulationsCompletedNCT02083640Phase 1
- A Multiple Dose Study Of PF-06678552 In Healthy SubjectsCompletedNCT02079922Phase 1
- Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male SubjectsCompletedNCT02070939Phase 1
- A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)CompletedNCT02070289Phase 1
- A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese VolunteersCompletedNCT02066909Phase 1
- A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese SubjectsCompletedNCT02059330Phase 1